GREAT POINT PARTNERS LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 86 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2021$29,444,000
-30.8%
930,000
+1.4%
6.08%
-12.0%
Q4 2020$42,569,000
-66.6%
917,427
-76.3%
6.91%
-39.8%
Q3 2020$127,618,000
+24.8%
3,876,600
+4.1%
11.48%
+40.5%
Q2 2020$102,251,000
+43.1%
3,724,976
+56.0%
8.17%
+9.5%
Q1 2020$71,473,000
-48.5%
2,387,606
-52.4%
7.47%
-38.2%
Q4 2019$138,820,000
+39.7%
5,015,175
-8.2%
12.09%
+32.4%
Q3 2019$99,387,000
-99.9%
5,460,8030.0%9.13%
-38.6%
Q2 2019$133,899,000,000
+252802.1%
5,460,803
-1.9%
14.86%
+183.7%
Q1 2019$52,945,000
+7.5%
5,567,3480.0%5.24%
-15.9%
Q4 2018$49,271,000
+25.3%
5,567,348
+59.2%
6.23%
+1.6%
Q3 2018$39,334,000
-11.8%
3,496,340
+0.3%
6.13%
-0.9%
Q2 2018$44,618,000
-99.9%
3,485,745
+5.0%
6.18%
-25.8%
Q1 2018$56,128,000,000
+350700.0%
3,321,173
+66.1%
8.34%
+205.3%
Q4 2017$16,000,000
+3.2%
2,000,0000.0%2.73%
-9.5%
Q3 2017$15,500,000
+1148.0%
2,000,000
+1083.3%
3.02%
+1252.0%
Q2 2017$1,242,000169,0140.22%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders